Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mangoceuticals (MGRX) Return on Sales (2023 - 2025)

Mangoceuticals (MGRX) has disclosed Return on Sales for 3 consecutive years, with 29.35% as the latest value for Q4 2025.

  • Quarterly Return on Sales fell 1083.0% to 29.35% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 45.27% through Dec 2025, down 3113.0% year-over-year, with the annual reading at 45.27% for FY2025, 3113.0% down from the prior year.
  • Return on Sales hit 29.35% in Q4 2025 for Mangoceuticals, up from 90.43% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 7.34% in Q3 2023 to a low of 90.43% in Q3 2025.
  • Historically, Return on Sales has averaged 26.25% across 3 years, with a median of 17.34% in 2023.
  • Biggest five-year swings in Return on Sales: surged 1437bps in 2024 and later crashed -7544bps in 2025.
  • Year by year, Return on Sales stood at 10.51% in 2023, then tumbled by -76bps to 18.51% in 2024, then crashed by -59bps to 29.35% in 2025.
  • Business Quant data shows Return on Sales for MGRX at 29.35% in Q4 2025, 90.43% in Q3 2025, and 32.22% in Q2 2025.